CRDF — CARDIFF ONCOLOGY INC

Ownership history in PFIZER INC  ·  5 quarters on record

This page tracks every 13F SEC filing in which PFIZER INC reported a position in CARDIFF ONCOLOGY INC (CRDF). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
2.87% (2025 Q4)
Avg. % of fund
1.45%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 2,411,575 — 0% 2.87% $6.8M $2.81
2025 Q3 UNCHANGED 2,411,575 — 0% 1.14% $5.0M $2.06
2025 Q2 UNCHANGED 2,411,575 — 0% 1.32% $7.6M $3.15
2025 Q1 UNCHANGED 2,411,575 — 0% 1.51% $7.57B $3.14
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CRDF price (monthly, adj. close)

Other funds also holding CRDF

As of 2025 Q4 — sorted by position size

ACORN CAPITAL ADVISORS, LLC 1.87% Laurion Capital Management LP 3Y 7Y 0.23% ELKHORN PARTNERS LIMITED PARTNERSHIP 3Y 7Y 0.07% Post Resch Tallon Group Inc. 0.05% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.05% FinDec Wealth Services, Inc. 3Y 0.05% Avestar Capital, LLC 3Y 7Y 0.02% FLPUTNAM INVESTMENT MANAGEMENT CO 3Y 7Y 0.02% XTX Topco Ltd 3Y 0.02% BLAIR WILLIAM & CO/IL 3Y 7Y 0.01%
← Back to PFIZER INC Holdings